6-YEAR EXPERIENCE WITH A COMPREHENSIVE APPROACH TO THE TREATMENT OF RECURRENT CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL-REZ BFM 85) - A RELAPSE STUDY OF THE BFM GROUP

被引：0
|
作者：
HENZE, G
FENGLER, R
HARTMANN, R
KORNHUBER, B
JANKASCHAUB, G
NIETHAMMER, D
RIEHM, H
机构：
来源：
BLOOD | 1991年 / 78卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1166 / 1172
页数：7
相关论文
共 50 条
  • [31] INCIDENCE OF INFECTIOUS COMPLICATIONS DURING INDUCTION-PHASE OF TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) WITH BFM LIKE REGIMEN
    BRICHON, P
    BERTRAND, Y
    PARIS, A
    BARBE, G
    COCHAT, N
    SOUILLET, G
    PHILIPPE, N
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 404 - 404
  • [32] Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Group
    von Stackelberg, Arend
    Voelzke, Enrico
    Kuehl, Joern-Sven
    Seeger, Karl
    Schrauder, Andre
    Escherich, Gabriele
    Henze, Guenter
    Tallen, Gesche
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (01) : 90 - 97
  • [33] Molecular Response to Treatment Predicts Outcome in Isolated, but Not in Combined Bone Marrow Relapses of Childhood Acute Lymphoblastic Leukaemia: Interim Results of Trial ALL-REZ BFM 2002.
    Eckert, Cornelia
    Stackelberg, Arend
    Hagedorn, Nikola
    Barth, Andrea
    Seeger, Karl
    Henze, Guenter
    BLOOD, 2008, 112 (11) : 873 - 873
  • [34] Treatment of recurrences of acute lymphoblastic leukemia (ALL) in children: results of BFM group and 7-year original investigations.
    Karachunsky, AI
    Belikova, LY
    Stakelberg, A
    Baidun, LV
    Rumyantsev, AG
    Kravchenko, EG
    Myakova, NV
    Trubina, NM
    Henze, G
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1998, 43 (06): : 8 - 13
  • [35] FAVORABLE OUTCOME OF B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD - A REPORT OF 3 CONSECUTIVE STUDIES OF THE BFM GROUP
    REITER, A
    SCHRAPPE, M
    LUDWIG, WD
    LAMPERT, F
    HARBOTT, J
    HENZE, G
    NIEMEYER, CM
    GADNER, H
    MULLERWEIHRICH, S
    RITTER, J
    ODENWALD, E
    RIEHM, H
    BLOOD, 1992, 80 (10) : 2471 - 2478
  • [36] Down syndrome with relapsed all - Inferior outcome due to worse tolerance to treatment. A matched pair analysis of the ALL-REZ BFM Study Group
    von Stackelberg, Arend
    Baumann, Fabian
    Escherich, Gabriele
    Schrappe, Martin
    Henze, Guenter
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 435 - 435
  • [37] CHEMOTHERAPY IN 998 UNSELECTED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS - RESULTS AND CONCLUSIONS OF THE MULTICENTER TRIAL ALL-BFM-86
    REITER, A
    SCHRAPPE, M
    LUDWIG, WD
    HIDDEMANN, W
    SAUTER, S
    HENZE, G
    ZIMMERMANN, M
    LAMPERT, F
    HAVERS, W
    NIETHAMMER, D
    ODENWALD, E
    RITTER, J
    MANN, G
    WELTE, K
    GADNER, H
    RIEHM, H
    BLOOD, 1994, 84 (09) : 3122 - 3133
  • [38] THE INVIVO RESPONSE ON CORTICOSTEROID-THERAPY AS AN ADDITIONAL PROGNOSTIC FACTOR IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (THERAPY STUDY ALL-BFM 83)
    RIEHM, H
    REITER, A
    SCHRAPPE, M
    BERTHOLD, F
    DOPFER, R
    GEREIN, V
    LUDWIG, R
    RITTER, J
    STOLLMANN, B
    HENZE, G
    KLINISCHE PADIATRIE, 1987, 199 (03): : 151 - 160
  • [39] Osteonecrosis:: A treatment related toxicity in childhood acute lymphoblastic leukemia (ALL) -: Experiences from trial ALL-BFM 95
    Bürger, B
    Beier, R
    Zimmermann, M
    Beck, JD
    Reiter, A
    Schrappe, M
    PEDIATRIC BLOOD & CANCER, 2005, 44 (03) : 220 - 225
  • [40] RELAPSE PATTERN AFTER TREATMENT SUSPENSION (TS) IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    ZURLO, MG
    SENESI, E
    PASTORE, G
    AMICI, A
    BASSO, G
    CALCULLI, C
    DITULLIO, MT
    HAUPT, R
    MACCHIA, P
    MAGRO, S
    MANCINI, A
    MELONI, G
    MINIERO, R
    SARACCO, P
    MASERA, G
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 392 - 393
12345